Ilaria Mannucci,Nghi D. P. Dang,Hannes Huber,Jaclyn B. Murry,Jeff Abramson,Thorsten Althoff,Siddharth Banka,Gareth Baynam,David Bearden,Ana Beleza-Meireles,Paul J. Benke,Siren Berland,Tatjana Bierhals,Frederic Bilan,Laurence A. Bindoff,Geir Julius Braathen,Øyvind L. Busk,Jirat Chenbhanich,Jonas Denecke,Luis F. Escobar,Caroline Estes,Julie Fleischer,Daniel Groepper,Charlotte A. Haaxma,Maja Hempel,Yolanda Holler-Managan,Gunnar Houge,Adam Jackson,Laura Kellogg,Boris Keren,Catherine Kiraly-Borri,Cornelia Kraus,Christian Kubisch,Gwenael Le Guyader,Ulf W. Ljungblad,Leslie Manace Brenman,Julian A. Martinez-Agosto,Matthew Might,David T. Miller,Kelly Q. Minks,Billur Moghaddam,Caroline Nava,Stanley F. Nelson,John M. Parant,Trine Prescott,Farrah Rajabi,Hanitra Randrianaivo,Simone F. Reiter,Janneke Schuurs-Hoeijmakers,Perry B. Shieh,Anne Slavotinek,Sarah Smithson,Alexander P. A. Stegmann,Kinga Tomczak,Kristian Tveten,Jun Wang,Jordan H. Whitlock,Christiane Zweier,Kirsty McWalter,Jane Juusola,Fabiola Quintero-Rivera,Utz Fischer,Nan Cher Yeo,Hans-Jürgen Kreienkamp,Davor Lessel

Abstract:Abstract Background We aimed to define the clinical and variant spectrum and to provide novel molecular insights into the DHX30 -associated neurodevelopmental disorder. Methods Clinical and genetic data from affected individuals were collected through Facebook-based family support group, GeneMatcher, and our network of collaborators. We investigated the impact of novel missense variants with respect to ATPase and helicase activity, stress granule (SG) formation, global translation, and their effect on embryonic development in zebrafish. SG formation was additionally analyzed in CRISPR/Cas9-mediated DHX30 -deficient HEK293T and zebrafish models, along with in vivo behavioral assays. Results We identified 25 previously unreported individuals, ten of whom carry novel variants, two of which are recurrent, and provide evidence of gonadal mosaicism in one family. All 19 individuals harboring heterozygous missense variants within helicase core motifs (HCMs) have global developmental delay, intellectual disability, severe speech impairment, and gait abnormalities. These variants impair the ATPase and helicase activity of DHX30, trigger SG formation, interfere with global translation, and cause developmental defects in a zebrafish model. Notably, 4 individuals harboring heterozygous variants resulting either in haploinsufficiency or truncated proteins presented with a milder clinical course, similar to an individual harboring a de novo mosaic HCM missense variant. Functionally, we established DHX30 as an ATP-dependent RNA helicase and as an evolutionary conserved factor in SG assembly. Based on the clinical course, the variant location, and type we establish two distinct clinical subtypes. DHX30 loss-of-function variants cause a milder phenotype whereas a severe phenotype is caused by HCM missense variants that, in addition to the loss of ATPase and helicase activity, lead to a detrimental gain-of-function with respect to SG formation. Behavioral characterization of dhx30 -deficient zebrafish revealed altered sleep-wake activity and social interaction, partially resembling the human phenotype. Conclusions Our study highlights the usefulness of social media to define novel Mendelian disorders and exemplifies how functional analyses accompanied by clinical and genetic findings can define clinically distinct subtypes for ultra-rare disorders. Such approaches require close interdisciplinary collaboration between families/legal representatives of the affected individuals, clinicians, molecular genetics diagnostic laboratories, and research laboratories.

A de novo pathogenic variant in DHX30 gene in a fetus with isolated dysgenesis of the corpus callosum

Prenatal Phenotypic Expansion: A Fetus with Neurodegeneration with Developmental Delay, Early Respiratory Failure, Myoclonic Seizures, and Brain Abnormalities (NDDRSB) and MED11 Variants.

Prenatal Diagnosis of a KIDINS220 De Novo Heterozygous Variant in a Fetus With a Complex CNS Anomaly

Case Report: Prenatal Diagnosis of Fetal Intracranial Hemorrhage Due to Compound Mutations in the JAM3 Gene

Whole-Exome Sequencing Revealed Mutations of MED12 and EFNB1 in Fetal Agenesis of the Corpus Callosum

Prenatal diagnosis of a likely pathogenic variant in ZBTB18: Natural evolution of fetal phenotype including the long bones and corpus callosum

Concurrent of compound heterozygous variant of a novel in-frame deletion and the common hypomorphic haplotype in TBX6 and inherited 17q12 microdeletion in a fetus

Genotype–phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders

Prenatal diagnosis of developmental and epileptic encephalopathy 9 with a 10.05-Mb microdeletion at Xq21.31q22.1 inherited from mother: A case report and literature review

A Novel Frameshift CHD4 Variant Leading to Sifrim-Hitz-Weiss Syndrome in a Proband with a Subclinical Familial t(17;19) and a Large dup(2)(q14.3q21.1)

Fetus with multiple congenital anomaly syndrome caused by novel variant in ATP1A2

An unusual presentation of de novo RAC3 variation in prenatal diagnosis

Prenatal diagnosis of a de novo 10p12.1p11.23 microdeletion encompassing the WAC gene in a fetus associated with bilateral hydronephrosis and right clubfoot on prenatal ultrasound

Genotype–phenotype correlation study of structural abnormalities in a fetal brain caused by a novel KDM4B variant

Prenatal phenotype of a homozygous nonsense MPDZ variant in a fetus with severe congenital hydrocephalus

A novel MED12 pathogenic variant in a female fetus with facial cleft and cardiac defects identified in the first trimester

Discordant Semilobar Holoprosencephaly in Monozygotic Twins with de novo inv dup(15) Marker Chromosome and de novo Mutation on SHH Gene

Monoallelic de novo variants in DDX17 cause a neurodevelopmental disorder

A novel de novo frameshift variant in the CHD2 gene related to intellectual and developmental disability, seizures and speech problems

A novel variant in IFT122 associated with a severe phenotype of cranioectodermal dysplasia

Fetal Congenital Heart Disease Caused by Compound Heterozygous Mutations in the DNAH9 Gene: A Case Report